Table 3.
Most frequently prescribed antimicrobials and indications for prophylaxis, by body systema
| All antimicrobials [systemic and topical] (n = 4739) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Rank | Urinary tract (54.3%, n = 2575) | Skin, soft tissue or mucosal (18.1%, n = 858) | Respiratory tract (7.3%, n = 348) | ||||||
| Antimicrobial/indication | No. | % | Antimicrobial/indication | No. | % | Antimicrobial/indication | No. | % | |
| 1 | Cefalexin | 1035 | 40.2 | Clotrimazole | 371 | 43.2 | Doxycycline | 173 | 49.7 |
| 2 | Methenamine hippurate | 879 | 34.1 | Cefalexin | 117 | 13.6 | Cefalexin | 31 | 8.9 |
| 3 | Trimethoprim | 239 | 9.3 | Doxycycline | 55 | 6.4 | Azithromycin | 25 | 7.2 |
| 1 | Cystitis | 1681 | 65.3 | Other skin, soft tissue or mucosal | 473 | 55.1 | Infective exacerbation of COPD | 121 | 34.8 |
| 2 | Other—urinary | 397 | 15.4 | Wound infection: non-surgical | 96 | 11.2 | Pneumonia | 84 | 24.1 |
| 3 | Asymptomatic bacteriuria | 272 | 10.6 | Tinea | 83 | 9.7 | Other—respiratory tract | 78 | 22.4 |
| Systemic antimicrobials only (n = 3923) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Rank | Urinary tract (65.5%, n = 2571) | Respiratory tract (8.9%, n = 348) | Skin, soft tissue or mucosal (7.3%, n = 288) | ||||||
| Antimicrobial/indication | No. | % | Antimicrobial/indication | No. | % | Antimicrobial/indication | No. | % | |
| 1 | Cefalexin | 1035 | 40.2 | Doxycycline | 173 | 49.7 | Cefalexin | 117 | 40.6 |
| 2 | Methenamine hippurate | 879 | 34.1 | Cefalexin | 31 | 8.9 | Doxycycline | 55 | 19.1 |
| 3 | Trimethoprim | 239 | 9.3 | Azithromycin | 25 | 7.2 | Amoxicillin—clavulanic acid | 17 | 5.9 |
| 1 | Cystitis | 1681 | 65.4 | Infective exacerbation of COPD | 121 | 34.8 | Other—skin, soft tissue or mucosal | 76 | 26.4 |
| 2 | Other—urinary tract | 394 | 15.3 | Pneumonia | 84 | 24.1 | Cellulitis | 64 | 22.2 |
| 3 | Asymptomatic bacteriuria | 272 | 10.6 | Other—respiratory tract | 78 | 22.4 | Wound infection: non-surgical | 63 | 21.9 |
COPD chronic obstructive pulmonary disease
a132 unknown indications for which an associated body system could not be assigned excluded from total numbers
Not detailed in the table, 8.2% and 9.7% of all and systemic-only prophylactic antimicrobials, respectively, were prescribed for medical prophylaxis indications